• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥厚型梗阻性心肌病与冠状动脉疾病的同期经皮治疗:一例报告

Simultaneous percutaneous treatment in hypertrophic obstructive cardiomyopathy and coronary artery disease: a case report.

作者信息

Seggewiss H, Faber L, Meyners W, Bogunovic N, Odenthal H J, Gleichmann U

机构信息

Kardiologische Klinik, Herz- und Diabeteszentrum NRW, Universitätsklinik der Ruhr-Universität Bochum, Bad Oeynhausen, Germany.

出版信息

Cathet Cardiovasc Diagn. 1998 May;44(1):65-9. doi: 10.1002/(sici)1097-0304(199805)44:1<65::aid-ccd16>3.0.co;2-o.

DOI:10.1002/(sici)1097-0304(199805)44:1<65::aid-ccd16>3.0.co;2-o
PMID:9600527
Abstract

Percutaneous transluminal coronary angioplasty (PTCA) is an established therapy for coronary artery disease (CAD), whereas percutaneous transluminal septal myocardial ablation (PTSMA) is becoming increasingly significant in the therapy of symptomatic patients with hypertrophic obstructive cardiomyopathy (HOCM). We report the first ever simultaneous treatment, in a 62-yr-old patient, of significant HOCM and a 75% LAD stenosis from which the septal branch to be occluded stemmed. Using a double wire technique, first the septal branch was occluded through a fractional injection of 4 ml absolute alcohol, thus ablating the hypertrophied septal myocardium with reduction of the left ventricular outflow tract (LVOT) gradient at rest from 80 to 9 mmHg. Following this, the LAD stenosis was dilated and stented. Complications, in particular a trifascicular block or ventricular dysrhythmia, did not occur during the hospital stay. To conclude, combined PTSMA and PTCA may be considered as a therapeutic alternative to a combined surgical intervention in individual cases of symptomatic HOCM and CAD, provided that the potential complications are taken into account.

摘要

经皮腔内冠状动脉成形术(PTCA)是治疗冠状动脉疾病(CAD)的一种成熟疗法,而经皮腔内室间隔心肌消融术(PTSMA)在有症状的肥厚性梗阻性心肌病(HOCM)患者的治疗中变得越来越重要。我们报告了首例对一名62岁患者同时进行显著HOCM和75%左前降支(LAD)狭窄治疗的案例,要闭塞的间隔支起源于该狭窄处。采用双线技术,首先通过分次注入4毫升无水乙醇闭塞间隔支,从而消融肥厚的室间隔心肌,使静息时左心室流出道(LVOT)压差从80 mmHg降至9 mmHg。在此之后,扩张并置入LAD狭窄处支架。住院期间未发生并发症,尤其是三分支阻滞或室性心律失常。总之,在有症状的HOCM和CAD的个别病例中,若考虑到潜在并发症,联合PTSMA和PTCA可被视为联合手术干预的一种治疗选择。

相似文献

1
Simultaneous percutaneous treatment in hypertrophic obstructive cardiomyopathy and coronary artery disease: a case report.肥厚型梗阻性心肌病与冠状动脉疾病的同期经皮治疗:一例报告
Cathet Cardiovasc Diagn. 1998 May;44(1):65-9. doi: 10.1002/(sici)1097-0304(199805)44:1<65::aid-ccd16>3.0.co;2-o.
2
[Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results in 66 patients with reference to myocardial contrast echocardiography].[经皮腔内室间隔心肌消融术治疗肥厚型梗阻性心肌病:66例患者的急性结果及心肌对比超声心动图分析]
Z Kardiol. 1998 Mar;87(3):191-201. doi: 10.1007/s003920050171.
3
Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients.经皮腔内室间隔心肌消融术治疗肥厚型梗阻性心肌病:25例患者的急性结果及3个月随访
J Am Coll Cardiol. 1998 Feb;31(2):252-8. doi: 10.1016/s0735-1097(97)00508-1.
4
Successful coronary stenting of the left anterior descending artery at the branching site of the targeted septal perforator immediately after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy.肥厚性梗阻性心肌病患者经皮腔内间隔心肌消融术后,于目标间隔支穿支分支部位成功进行左前降支冠状动脉支架置入术。
Intern Med. 2005 Jul;44(7):722-6. doi: 10.2169/internalmedicine.44.722.
5
Percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy.肥厚型梗阻性心肌病的经皮腔内室间隔消融术
Thorac Cardiovasc Surg. 1999 Apr;47(2):94-100. doi: 10.1055/s-2007-1013118.
6
[Percutaneous transluminal ablation of the myocardial septum by embolization of the first branch of the anterior descending coronary artery using a small amount of absolute alcohol].[使用少量无水乙醇栓塞冠状动脉前降支第一分支行经皮腔内心肌间隔消融术]
Srp Arh Celok Lek. 2001 Jul-Aug;129(7-8):199-202.
7
Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Acute results and three-year noninvasive follow-up in 18 patients.经皮腔内室间隔心肌消融术治疗肥厚性梗阻性心肌病:18例患者的急性结果及三年无创随访
Can J Cardiol. 2004 Jun;20(8):779-82.
8
Early remodelling of left ventricle and improvement of myocardial performance in patients after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy.肥厚性梗阻性心肌病患者经皮腔内室间隔心肌消融术后左心室的早期重塑及心肌性能改善
Int J Cardiol. 2003 Mar;88(1):27-32. doi: 10.1016/s0167-5273(02)00381-9.
9
[Percutaneous transluminal septal myocardial ablation: early results and long-term follow-up].[经皮腔内室间隔心肌消融术:早期结果及长期随访]
Przegl Lek. 2006;63(8):628-32.
10
Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy through non-left anterior descending septal perforators.经非左前降支间隔穿支血管行肥厚型梗阻性心肌病经皮腔内间隔心肌消融术
Heart Vessels. 2020 May;35(5):647-654. doi: 10.1007/s00380-019-01525-8. Epub 2019 Oct 22.

引用本文的文献

1
Acute Left Ventricular Ballooning: Tools to Differentiate Hypertrophic Cardiomyopathy with Outflow Obstruction from Neurohumoral Takotsubo Syndrome.急性左心室气球样变:鉴别肥厚型心肌病伴流出道梗阻与神经体液性应激性心肌病的工具
Rev Cardiovasc Med. 2023 May 19;24(5):154. doi: 10.31083/j.rcm2405154. eCollection 2023 May.
2
Transcatheter septal ablation in hypertrophic obstructive cardiomyopathy: a technical guide and review of published results.经导管间隔消融术治疗肥厚型梗阻性心肌病:技术指南和文献研究结果回顾。
Heart Fail Rev. 2018 Nov;23(6):907-917. doi: 10.1007/s10741-018-9706-z.
3
Twenty Years of Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy.
肥厚性梗阻性心肌病酒精间隔消融二十年
Curr Cardiol Rev. 2016;12(4):285-296. doi: 10.2174/1573403x11666150107160344.
4
Current status of alcohol septal ablation for patients with hypertrophic cardiomyopathy.肥厚型心肌病患者酒精间隔消融术的现状
Curr Cardiol Rep. 2001 Mar;3(2):160-6. doi: 10.1007/s11886-001-0044-7.
5
[Clinical picture and therapy of hypertrophic cardiomyopathy].
Med Klin (Munich). 1998 Apr 15;93(4):260-7. doi: 10.1007/BF03044802.